In the run-up to a full characterization of PC at molecular level, up to one fifth of cases from a recent large single-institution series showed alterations of the PI3K/AKT/mTOR oncogenic pathway, and about a third had Cyclin D1 overexpression supported by its relative CCND1 gene amplification [43]. This evidence concerns the gene MTOR and pachyonychia congenita.